Bavarian Nordic A/S (BVNRY)
| Previous close | 16.22 |
| Open | 16.34 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 16.00 - 18.23 |
| 52-week range | 5.85 - 19.31 |
| Volume | |
| Avg. volume | 249,801 |
| Market cap | 3.7B |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.61 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Mar 2020 |
| 1y target est | N/A |
- Editor's pickYahoo Finance Video
U.S. negotiates terms with Bavarian Nordic on monkeypox vaccine production
Yahoo Finance's Anjalee Khemlani breaks down the new deal the U.S. and sole monkeypox vaccine maker have reached to speed up vaccine distribution.
- Editor's pickYahoo Finance
U.S. government asks monkeypox vaccine maker Bavarian Nordic to find partners
The U.S. government asks Bavarian Nordic, the sole manufacturer of a monkeypox vaccine, to find new partners.
- Bloomberg
US Will Start Making Bavarian Nordic's Monkeypox Shot
(Bloomberg) -- The Biden administration is aiming to ramp up supplies of scarce monkeypox vaccine by clearing the way for a deal between manufacturer Bavarian Nordic A/S and a Michigan-based company to finish packaging millions of doses in the US.Most Read from BloombergApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysCovid’s Harmful Effects on the Brain Reverberate Years LaterBiden's Next Grand Bargain Could Retire Tr
